|
US2956062A
(en)
|
1959-02-26 |
1960-10-11 |
Robins Co Inc A H |
Esters of amino alcohols
|
|
GB1200886A
(en)
|
1966-09-23 |
1970-08-05 |
Allen & Hanburys Ltd |
Phenylaminoethanol derivatives
|
|
US3994974A
(en)
|
1972-02-05 |
1976-11-30 |
Yamanouchi Pharmaceutical Co., Ltd. |
α-Aminomethylbenzyl alcohol derivatives
|
|
SE378109B
(https=)
|
1972-05-19 |
1975-08-18 |
Bofors Ab |
|
|
US4187301A
(en)
|
1978-04-05 |
1980-02-05 |
Syntex (U.S.A.) Inc. |
17 Beta-thiocarboxylic acid esters of 6 alpha, 6 beta-difluoro-3-oxoandrost-4-enes
|
|
BE887518A
(fr)
|
1980-02-15 |
1981-08-13 |
Glaxo Group Ltd |
Cartothioates d'androstanes
|
|
CY1359A
(en)
|
1981-02-02 |
1987-08-07 |
Schering Corp |
Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
|
|
ZW6584A1
(en)
|
1983-04-18 |
1985-04-17 |
Glaxo Group Ltd |
Phenethanolamine derivatives
|
|
US5707634A
(en)
|
1988-10-05 |
1998-01-13 |
Pharmacia & Upjohn Company |
Finely divided solid crystalline powders via precipitation into an anti-solvent
|
|
GB8903593D0
(en)
|
1989-02-16 |
1989-04-05 |
Pafra Ltd |
Storage of materials
|
|
US5610163A
(en)
|
1989-09-16 |
1997-03-11 |
Boehringer Ingelheim Gmbh |
Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
|
|
DE3931041C2
(de)
|
1989-09-16 |
2000-04-06 |
Boehringer Ingelheim Kg |
Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
|
|
SE9302777D0
(sv)
|
1993-08-27 |
1993-08-27 |
Astra Ab |
Process for conditioning substances
|
|
AU659645B2
(en)
|
1991-06-26 |
1995-05-25 |
Inhale Therapeutic Systems |
Storage of materials
|
|
US6582728B1
(en)
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
|
GB9313642D0
(en)
|
1993-07-01 |
1993-08-18 |
Glaxo Group Ltd |
Method and apparatus for the formation of particles
|
|
SE9404080L
(sv)
|
1993-12-28 |
1995-06-29 |
Ciba Geigy Ag |
Förfarande för framställning av en optiskt ren enantiomer av formoterol
|
|
US5837699A
(en)
|
1994-01-27 |
1998-11-17 |
Schering Corporation |
Use of mometasone furoate for treating upper airway passage diseases
|
|
GB9413202D0
(en)
|
1994-06-30 |
1994-08-24 |
Univ Bradford |
Method and apparatus for the formation of particles
|
|
DE4440337A1
(de)
|
1994-11-11 |
1996-05-15 |
Dds Drug Delivery Services Ges |
Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
|
|
US6309671B1
(en)
|
1995-04-14 |
2001-10-30 |
Inhale Therapeutic Systems |
Stable glassy state powder formulations
|
|
US6258341B1
(en)
|
1995-04-14 |
2001-07-10 |
Inhale Therapeutic Systems, Inc. |
Stable glassy state powder formulations
|
|
ATE287703T1
(de)
|
1995-04-14 |
2005-02-15 |
Nektar Therapeutics |
Pulverförmige pharmazeutische formulierungen mit verbesserter dispergierbarkeit
|
|
US5833891A
(en)
|
1996-10-09 |
1998-11-10 |
The University Of Kansas |
Methods for a particle precipitation and coating using near-critical and supercritical antisolvents
|
|
US5886200A
(en)
|
1996-07-01 |
1999-03-23 |
Schering Corporation |
Process for the preparation of 17-esters of 9 α, 21-dihalo-pregnane-11 β, 17 α-diol-20-ones
|
|
US6040344A
(en)
|
1996-11-11 |
2000-03-21 |
Sepracor Inc. |
Formoterol process
|
|
US6010935A
(en)
|
1997-08-21 |
2000-01-04 |
Micron Technology, Inc. |
Self aligned contacts
|
|
US6309623B1
(en)
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
|
NZ500555A
(en)
|
1999-08-02 |
2000-11-24 |
Hovione Int Ltd |
Process for the preparation of mometasone furoate
|
|
NZ518401A
(en)
|
1999-10-29 |
2004-01-30 |
Nektar Therapeutics |
Dry powder compositions having improved dispersivity
|
|
PT1280520E
(pt)
|
2000-05-10 |
2014-12-16 |
Novartis Ag |
Pós à base de fosfolípidos para administração de fármacos
|
|
US6908928B2
(en)
|
2000-10-12 |
2005-06-21 |
Bi Pharma Kg. |
Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
|
|
ES2335498T3
(es)
|
2003-03-10 |
2010-03-29 |
Nycomed Gmbh |
Nuevo proceso para la preparacion de reflumilast.
|
|
KR20060015316A
(ko)
|
2003-05-28 |
2006-02-16 |
넥타르 테라퓨틱스 |
아미노산 및/또는 인지질로 부분 또는 완전 코팅된수불용성 활성제 미립자의 제조를 위한 알코올성 수용액의분무 건조법
|
|
AU2006272438B2
(en)
|
2005-07-15 |
2011-08-04 |
Map Pharmaceuticals, Inc. |
Method of particle formation
|
|
CN100560598C
(zh)
|
2005-07-26 |
2009-11-18 |
上海奥锐特国际贸易有限公司 |
氟替卡松丙酸酯的合成方法
|
|
GB0801876D0
(en)
*
|
2008-02-01 |
2008-03-12 |
Vectura Group Plc |
Suspension formulations
|
|
US8815258B2
(en)
*
|
2009-05-29 |
2014-08-26 |
Pearl Therapeutics, Inc. |
Compositions, methods and systems for respiratory delivery of two or more active agents
|
|
PL3111927T3
(pl)
|
2009-05-29 |
2020-06-29 |
Pearl Therapeutics, Inc. |
Kompozycje do wziewnego podawania środków aktywnych oraz związane z nimi sposoby i systemy
|
|
CN104080770A
(zh)
|
2011-11-09 |
2014-10-01 |
迈兰实验室有限公司 |
用于制备罗氟司特的改进方法
|
|
WO2014060464A1
(en)
|
2012-10-17 |
2014-04-24 |
Interquim, S.A. |
Process for preparing roflumilast
|
|
US20150150787A1
(en)
*
|
2013-05-22 |
2015-06-04 |
Pearl Therapeutics, Inc. |
Compositions, methods & systems for respiratory delivery of three or more active agents
|
|
IL295269A
(en)
*
|
2020-02-20 |
2022-10-01 |
Chiesi Farm Spa |
Inhalers with a measured dose under pressure that include the composition of pharmacy buffers
|